Author:
Ueda Toyofumi,Naito Seiji,Iguchi Atsushi,Sagiyama Kazuyuki,Osada Yukio,Ariyoshi Asami,Omoto Tetsuo,Kumazawa Joichi,
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference14 articles.
1. Cross RJ, Glashan RW, Humphrey CS, Robinson MRG, Smith PH, Williams RE (1976) Treatment of advanced bladder cancer with Adriamycin and 5-fluorouracil. Br J Urol 48:609
2. Denis L, Bouffioux C, Kurth KH, Debruyne F, Sylvester R, De Pauw M, Members of the EORTC Urological Group (1987) Current status of intravesical chemotherapy trials in the EORTC Urological Group. An overview. Cancer Chemother Pharmacol 20 [Suppl]:S67
3. Fosså SD, Gudmundsen TE (1981) Single drug chemotherapy with 5-FU and Adriamycin in metastatic bladder carcinoma. Br J Urol 53:320
4. Leissner KH, Gustavsson B (1982) Oral administration of 5-fluorouracil: renal clearance and urinary concentration in man. J Urol 128:697
5. Niijima T, Koiso K, Akaza H, the Japanese Urological Cancer Research Group for Adriamycin (1983) Randomized clinical trial on chemoprophylaxis of recurrence in cases of superficial bladder cancer. Cancer Chemother Pharmacol 11 [Suppl]:S79